Illumina Inc

ILMN

NASDAQ. Currency in USD

191.59 -7.95 ( -3.98% )

Real time prices: December 19

Market Cap.
30.14B
Beta (5Y monthly)
1.13
Price/Earnings
77.08
EPS (TTM)
2.73
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.20M
1y Target Est.
249.11
Day's Range
190.75
-
199.44
52 Week's Range
173.45
-
371.16

Historical Summary

Performance
EPS growth
Share Buybacks

About Illumina Inc

Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.illumina.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
156.30M
Employees
9800
Address
5200 Illumina Way, San Diego, CA, United States, 92122
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Latest news

Is Illumina Cheap or Expensive?
Is Illumina Cheap or Expensive?

It depends on which numbers you focus on.
By The Motley Fool - 7 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022

Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral...
By Benzinga - 7 weeks ago

Tracking Al Gore's Generation Investment Management Portfolio - Q3 2022 Update
Tracking Al Gore's Generation Investment Management Portfolio - Q3 2022 Update

Al Gore's 13F portfolio value decreased from $18.35B to $16.86B this quarter. Find out Generation...
By Seeking Alpha - 8 weeks ago

Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina

Rosenblatt boosted the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $118 to $103. Rosenblatt...
By Benzinga - 11 weeks ago

What 12 Analyst Ratings Have To Say About Illumina
What 12 Analyst Ratings Have To Say About Illumina

Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: Bullish Somewhat Bullish...
By Benzinga - 12 weeks ago

11 Analysts Have This to Say About Illumina
11 Analysts Have This to Say About Illumina

Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: Bullish Somewhat Bullish...
By Benzinga - 13 weeks ago

Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings...
By Zacks Investment Research - 14 weeks ago

Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy?
Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy?

Bionano's stock price movements have little to do with its successes.
By The Motley Fool - 14 weeks ago